BioLife Solutions (BLFS) Statistics

BioLife Solutions Inc (BLFS) is a leading provider of biopreservation tools and services for the life sciences industry. The company specializes in developing and manufacturing proprietary biopreservation media and automated cell thawing devices that enable the effective storage and transport of cells, tissues, and organs. BLFS stock has gained significant attention from investors due to its strong financial performance and promising growth prospects. As of the latest valuation metrics, BLFS has a market capitalization of $1.5 billion, with a price-to-sales ratio of 20.5x and a price-to-earnings ratio of 65.2x.

The fundamentals of BioLife Solutions Inc also reflect its strong position in the industry. The company has shown consistent revenue growth over the years, with a revenue per share of $3.24. This indicates its ability to generate substantial sales from its products and services. Additionally, BioLife Solutions Inc has maintained a healthy profit margin of 12.4%, which is a positive sign for investors. Its efficient operational performance is further highlighted by its Enterprise to EBITDA ratio of 25.6x, showcasing its ability to generate earnings before interest, taxes, depreciation, and amortization.